Estrogen: Effects on normal brain function and neuropsychiatric disorders

Climacteric

Volumn 10, Issue SUPPL. 2, 2007, Pages 97-104

  Craig, M C ^a   Murphy, D G ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Brain function; Estrogen; Neuropsychiatric disorders

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NEUROTRANSMITTER;

ANTIOXIDANT ACTIVITY; BRAIN FUNCTION; BRAIN REGION; CHOLINERGIC SYSTEM; COGNITION; CONFERENCE PAPER; DEMENTIA; DOPAMINERGIC SYSTEM; DRUG EFFECT; FEMALE; HORMONE DEFICIENCY; HUMAN; MEMORY; MENTAL DISEASE; MOOD; NERVE CELL MEMBRANE; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; NEUROTROPISM; OVARY FUNCTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

AGING; ALZHEIMER DISEASE; BRAIN; COGNITION; COGNITION DISORDERS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; NERVOUS SYSTEM DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 34548836064     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130701598746     Document Type: Conference Paper

References (67)

1. Mitchell ES, Woods NF. Midlife women's attributions about perceived memory changes: observations from the Seattle Midlife Women's Health Study. J Women's Health Gender-Based Med 2001;10:351-62
2. Zandi PP, Carlson MC, Plassman BL, et al. for the Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women: The Cache County Study. JAMA 2002;288:2123-9
3. Sherwin BB. Estrogen and cognitive functioning in women. Endocr Rev 2003;24:133-51
4. Hampson E. Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cognition 1990;14:26-43
5. Hampson E. Estrogen-related variations in human spatial and articulatory-motor skills. Psychoneuroendocrinology 1990;15:97-111
6. Sherwin BB, Phillips S. Estrogen and cognitive functioning in surgically menopausal women. Ann N Y Acad Sci 1990;592
7. Jacobs DM, Tang MX, Stern Y, et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology 1998;50:368-73
8. Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 1994;83:979-83
9. Maki PM, Zonderman AB, Resnick SM. Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry 2001;158:227-33
10. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-57
11. Zec RF, Trivedi MA. The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review. Neuropsychol Rev 2002;12:65-109
12. LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001;285:1489-99
13. Craig MC, Maki PM, Murphy DGM. The Women's Health Initiative Memory Study: findings and implications for treatment. Lancet (Neurol) 2005;4:1-5
14. Shumaker SA, Legault C, Kuller L, et al. for the Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2947-58
15. Benes FM, Turtle M, Khan Y, Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry 1994;51:477-84
16. Giedd JN, Vaituzis AC, Hamburger SD, et al. Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: ages 4-18 years. J Comparative Neurol 1996;366:223-30
17. Kaye JADC, Luxenberg JS, Rapoport SI. The significance of age-related enlargement of the cerebral ventricles in healthy men and women measured by quantitative computed X-ray tomography. J Am Geriatr Soc 1992;40:225-32
18. Takeda SMT. Age-related brain atrophy: a study with computed tomography. J Gerentol 1985;40:159-63
19. Murphy DG, DeCarli C, McIntosh AR, et al. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry 1996;53:585-94
20. Resnick SM, Maki PM, Golski S, Kraut MA, Zonderman AB. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav 1998;34:171-82
21. Eberling JL, Wu C, Mungas D, Buoncore M, Jagurst J. Preliminary evidence that oestrogen protects against age-related hippocampal atrophy. Neurobiol Aging 2003;24:725-32
22. Eberling JL, Wu C, Tong-Turnbeaugh R, Jagurst J. Estrogen-and-tamoxifen- associated effects on brain structure and function. Neuroimage 2004;21:364-71
23. Brinton RD. 17-beta oestradiol induction of filipodial growth in cultured hippocampal neurones within minutes of exposure. Molec Cell Neurosci 1993;4:36-46
24. Woolley CS, McEwen BS. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle of the adult rat. J Neurosci 1992;12:2549-54
25. Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA. Oestradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci 1997;17:1848-59
26. Tanapat P, Hastings NB, Reeves AJ, Gould E. Oestrogen stimulates a transient increase in the number of new neurones in dentate gyrus of the adult female rat. J Neurosci 1999;19:5792-801
27. 1H-MRS study. Neurology 2001;57:2114-17
28. Jenden DJ. The metabolism of choline. Bull Clin Sci 1990;55:99-106
29. Pfefferbaum A, Adalsteinsson E, Speilman D, Sullivan EV, Lim KO. In vivo spectroscopic quantification of the N-acetyl-moiety, creatine, and choline from large volume of brain grey and white matter: the effects of normal aging. Magnetic Resonance Med 1999;41:276-84
30. Ernst T, Chang L, Cooray D, et al. The effects of tamoxifen and estrogen on brain metabolism in elderly women. J Natl Cancer Inst 2002;94:592-7
31. Brand A, Richter-Landsberg C, Leibfritz D. Multicentre NMR studies on the energy metabolism of glian and neuronal cells. Dev Neurosci 1993;15:289-98
32. Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 1999;52:100-8
33. Green PS, Gordon K, Simpkins JW. Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol 1997;63:229-35
34. Galli RL, Shukitt-Hale B, Youdim KA, Joseph JA. Fruit polyphenolics and brain ageing: nutritional interventions targeting age-related neuronal and behavioral deficits. Ann N Y Acad Sci 2002;959:128-32
35. Dietrich T, Krings T, Neulen J, et al. Effects of blood oestrogen level on cortical activation patterns during cognitive activation as measured by functional MRI. Neuroimage 2001;13:425-32
36. Fernandez G, Weis S, Stoffel-Wagner B, et al. Menstrual cycle-dependent neural plasticity in adult brain is hormone, task and region specific. J Neurosci 2003;29:3790-5
37. Berman KF, Schmidt PJ, Rubinow DR, et al. Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci USA 1997;94:8836-41
38. Resnick SM, Maki PM, Golski S, Kraut MA, Zonderman AB. Effects of oestrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav 1998;34:171-82
39. Eberling JL, Reed BR, Coleman JE, Jagurst J. Effect of oestrogen on cerebral glucose metabolism in postmenopausal women. Neurology 2000;55:875-7
40. Shaywitz SE, Shaywitz BA, Pugh KR, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999;281:1197-202
41. van Huizen F, March D, Cynader MS, Shaw C. Muscarinic receptor characteristics and regulation in rat cerebral cortex: changes during development, ageing and the oestrous cycle. Eur J Neurosci 1994;6:237-43
42. Gibbs RB. Effects of oestrogen on basal forebrain cholinergic neurones and cognition: implications for brain ageing and dementia in women. In Morrision M, ed. Hormones, Aging and Mental Disorders. Cambridge: Cambridge University Press, 2000:183-222
43. Gibbs RB, Hashash A, Johnstone DA. Effects of oestrogen on potassium-stimulated acetylcholine release in the hippocampus and overlying cortex of adult rats. Brain Res 1997;749:143-6
44. Gibbs RB, Burke AM, Johnson DA. Estrogen attenuates effects of scopolamine and lorazepam on memory acquisition and retention. Horm Behav 1998;34:112-25
45. Gibbs RB, Gabor R. Estrogen and cognition: applying preclinical findings to clinical perspectives. J Neurosci Res 2003;74:637-43
46. Gibbs RB. Long-term treatment with oestrogen and progesterone enhances acquisition of a spatial memory task by ovariectomised aged rats. Neurobiol Aging 2000;21:107-16
47. Markowska AL, Savonenko AV. Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J Neurosci 2002;22:10985-95
48. van Amelsvoort T, Murphy DGM, Robertson D, Daly E, Whitehead, Abel K. Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in healthy postmenopausal women. Psychoneuroendocrinology 2003;2003:101-12
49. Welt CK, Pagan YL, Smith PC, Rado KB, Hall JE. Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab 2003;88:1766-71
50. Leranth C, Roth RH, Elswoth JD, Naftolin F, Horvath TL, Redmond DE Jr. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci 2000;20:8604-9
51. Ohtani H, Nomoto M, Douchi T. Chronic estrogen treatment replaces striatal dopaminergic function in ovariectomized rats. Brain Res 2001;900:163-8
52. Levesque D, Di Paolo T. Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol. Neurosci Lett 1988;88:113-18
53. Gordon JH, Perry KO. Pre- and postsynaptic neurochemical alterations following estrogen induced hypersensitivity. Brain Res Bull 1983;10:425-8
54. Gordon JH. Modulation of apomorphine induced sterotypy by estrogen: time course and dose response. Brain Res Bull 1980;5:679-82
55. Wong DF, Wagner HN Jr, Dannals RF, et al. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 1984;226:1393-6
56. Wong DF, Broussolle EP, Wand G, et al. In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences. Ann N Y Acad Sci 1988;515:203-14
57. Ettigi P, Lal S, Martin JB, Friesen HC. Effects of sex, oral contraceptives, and glucose loading on apomorphine induced growth hormone secretion. J Clin Endocrinol Metab 1975;40:1094-8
58. Wieck A, Hirst AD, Kumar R, Checkley SA, Campbell IC. Growth hormone secretion by human females in response to apomorphine challenge is markedly affected by menstrual cycle phase. Br J Clin Pharmacol 1989;27:700-1P
59. Wieck A, Kumar R, Marks MN, Checkley SA. Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. Br Med J 1991;303:613-16
60. Craig M, Cutter W, Wickhham H, van Amelsvoort T, Murphy D. Effect of long-term estrogen therapy on dopaminergic responsivity in postmenopausal women. Psychoneuroendocrinology 2004;29:1309-16
61. Biegon A, McEwen BS. Modulation by estradiol of serotonin receptors in brain. J Neurosci 1982;2:199-205
62. Biegon A, Resches A, Snyder L, McEwen BS. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci 1983;32:2015-21
63. O'Keane V, O'Hanlon M, Webb M, Dinan T. d-fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration. Clin Endocrinol 1991;34:289-92
64. Van Amelsvoort TAMJ, Abel KM, Robertson DMR, et al. Prolactin response to d-fenfluramine in postmenopausal women on and off ERT: comparison with young women. Psychoneuroendocrinology 2001;26:494-502
65. Best NR, Rees MP, Barlow DH, Cowen PJ. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology 1992;17:87-93
66. Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 1995;37:434-41
67. Kugaya A, Epperson CN, Zoghbi S, et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 2003;160:1522-4